Back
Day Range
$165.96
$172.79
52-Week Range
$134.65
$247.05
Volume
907,148
50D / 200D Avg
$195.75
/
$195.50
Prev Close
$166.07
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 20.8 | 0.4 |
| P/B | 4.4 | 2.9 |
| ROE % | 21.6 | 3.7 |
| Net Margin % | 8.3 | 3.9 |
| Rev Growth 5Y % | 4.1 | 10.0 |
| D/E | 2.5 | 0.2 |
Analyst Price Target
Hold
$233.80
+40.0%
Low: $210.00
High: $258.00
Forward P/E
13.2
Forward EPS
$12.70
EPS Growth (est.)
+0.0%
Est. Revenue
17 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$19.50
$19.25 – $19.90
|
22 B | 6 |
| FY2029 |
$17.63
$17.39 – $17.99
|
21 B | 6 |
| FY2028 |
$15.66
$13.24 – $17.42
|
19 B | 8 |
Key Takeaways
Revenue grew 4.13% annually over 5 years — modest growth
ROE of 21.64% indicates high profitability
Debt/Equity of 2.49 — high leverage
Generating 2.05B in free cash flow
Cash machine — converts 150.81% of earnings into free cash flow
Capital efficient — spends only 3.70% of revenue on capex
Growth
Revenue Growth (5Y)
4.13%
Revenue (1Y)5.87%
Earnings (1Y)-0.95%
FCF Growth (3Y)16.93%
Quality
Return on Equity
21.64%
ROIC7.56%
Net Margin8.34%
Op. Margin14.02%
Safety
Debt / Equity
2.49
Current Ratio0.75
Interest Coverage3.14
Valuation
P/E Ratio
20.83
P/B Ratio4.36
EV/EBITDA18.60
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5.87% | Revenue Growth (3Y) | 4.33% |
| Earnings Growth (1Y) | -0.95% | Earnings Growth (3Y) | 0.07% |
| Revenue Growth (5Y) | 4.13% | Earnings Growth (5Y) | 8.93% |
| Profitability | |||
| Revenue (TTM) | 16.31B | Net Income (TTM) | 1.36B |
| ROE | 21.64% | ROA | 4.54% |
| Gross Margin | 26.28% | Operating Margin | 14.02% |
| Net Margin | 8.34% | Free Cash Flow (TTM) | 2.05B |
| ROIC | 7.56% | FCF Growth (3Y) | 16.93% |
| Safety | |||
| Debt / Equity | 2.49 | Current Ratio | 0.75 |
| Interest Coverage | 3.14 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 20.83 | P/B Ratio | 4.36 |
| P/S Ratio | 1.74 | PEG Ratio | 6.34 |
| EV/EBITDA | 18.60 | Dividend Yield | 0.00% |
| Market Cap | 28.33B | Enterprise Value | 42.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16.31B | 15.41B | 14.98B | 14.41B | 13.87B |
| Net Income | 1.36B | 1.37B | 1.36B | 1.09B | 966.00M |
| EPS (Diluted) | 7.84 | 7.49 | 7.29 | 5.72 | 4.95 |
| Gross Profit | 4.29B | 5.38B | 5.24B | 5.03B | 4.64B |
| Operating Income | 2.29B | 2.20B | 1.98B | 1.80B | 1.39B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29.94B | 26.90B | 26.68B | 25.34B | 24.69B |
| Total Liabilities | 23.31B | 20.83B | 20.57B | 19.57B | 18.65B |
| Shareholders' Equity | 6.50B | 6.07B | 6.11B | 5.77B | 6.04B |
| Total Debt | 16.17B | 14.16B | 13.90B | 13.01B | 12.44B |
| Cash & Equivalents | 1.98B | 1.70B | 1.38B | 1.22B | 1.37B |
| Current Assets | 6.25B | 5.83B | 5.60B | 4.98B | 4.76B |
| Current Liabilities | 8.34B | 6.96B | 6.49B | 5.58B | 5.24B |